Skip to content

Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs

Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs in Patients Undergoing Transurethral Resection

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04638569
Enrollment
116
Registered
2020-11-20
Start date
2021-02-16
Completion date
2022-09-01
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Succesful Obturator Nerve Block, Bladder Tumor, Bleeding

Keywords

obturator nerve block, bladder tumor, ultrasonografi, anatomical signs

Brief summary

Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.

Detailed description

The primary aim of this study is to compare the success rates of ONB techniques performed with ultrasound guided or blind technique. Its secondary purpose is to compare the effect of peroperative bleeding and control cystoscopy performed in the postoperative 3rd month on the presence of recurrent tumor.

Interventions

The ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle. In the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL. The time elapsed until the first needle insertion and local anesthetic injection is completed will be recorded as the application time.

Sponsors

Muğla Sıtkı Koçman University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Intervention model description

group 1; Ultrasound-guided obturator nerve block group 2; obturator nerve block with anatomical signs

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* ASA I-II patients

Exclusion criteria

* Tumors that disrupt the integrity of the bladder, * bladder floor tumors, * coagulation disorders, * motor in the lower limbs * with sensory disturbances, * uncooperative patients, * Known allergy to local anesthetics * patients with localized infection at the procedure site

Design outcomes

Primary

MeasureTime frameDescription
Preoperative succesful obturator nerve blockoperation timeperoperative adductor muscle spazm

Secondary

MeasureTime frameDescription
peroperative bleeding, Presence of recurrent tumor at postoperative 3rd month3 monthsperoperative bledding, Control by cystoscopy in the postoperative 3rd month recurrence tumor size

Countries

Turkey (Türkiye)

Contacts

Primary ContactEylem Yasar, MD
eylemtarakci@gmail.com00905332392622
Backup Contacteylem yasar
eylemtarakci@gmail.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026